ANITAC Trademark

Trademark Overview


On Friday, July 15, 2022, a trademark application was filed for ANITAC with the United States Patent and Trademark Office. The USPTO has given the ANITAC trademark a serial number of 79355612. The federal status of this trademark filing is REGISTERED as of Tuesday, December 19, 2023. This trademark is owned by ESSA Pharma Inc.. The ANITAC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemical compounds for pharmaceutical purposes and pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory diseases and central nervous system disorders

Scientific research in the field of pharmaceutical research and development, and research and design services relating thereto; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; clinical research in the field of cancer treatment; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; scientific research for medical purposes in the area of cancerous diseases; research and development services of technology in the fields of pharmaceuticals, oncology, immunology and immuno-oncology; providing scientific research information in the fields of pharmaceuticals, biotechnology and health sciences
anitac

General Information


Serial Number79355612
Word MarkANITAC
Filing DateFriday, July 15, 2022
Status700 - REGISTERED
Status DateTuesday, December 19, 2023
Registration Number7245195
Registration DateTuesday, December 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements


Goods and ServicesChemical compounds for pharmaceutical purposes and pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory diseases and central nervous system disorders
Goods and ServicesScientific research in the field of pharmaceutical research and development, and research and design services relating thereto; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; clinical research in the field of cancer treatment; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; scientific research for medical purposes in the area of cancerous diseases; research and development services of technology in the fields of pharmaceuticals, oncology, immunology and immuno-oncology; providing scientific research information in the fields of pharmaceuticals, biotechnology and health sciences

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 18, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameESSA Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCA

Party NameESSA Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCA

Party NameESSA Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCA

Trademark Events


Event DateEvent Description
Monday, April 1, 2024FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 1, 2024FINAL DISPOSITION PROCESSED
Tuesday, March 19, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 19, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 13, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 11, 2023REFUSAL PROCESSED BY IB
Monday, June 19, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 19, 2023REFUSAL PROCESSED BY MPU
Friday, May 12, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 2, 2023ASSIGNED TO EXAMINER
Tuesday, November 22, 2022APPLICATION FILING RECEIPT MAILED
Friday, November 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 17, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB